• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N6-甲基腺苷(mA)-信使核糖核酸(mRNA)甲基化调控基因表达以及利用CRISPR-Cas13b对肾细胞癌中细胞RNA进行可编程的mA修饰

mA-mRNA Methylation Regulates Gene Expression and Programmable mA Modification of Cellular RNAs With CRISPR-Cas13b in Renal Cell Carcinoma.

作者信息

Gan Ying, Li Aolin, Liu Jun, Wang Xiaofei, Zhang Zhenan, Li Qinhan, Ye Xiongjun, Yao Lin, Zhang Qian

机构信息

Department of Urology, Peking University First Hospital, Beijing, China.

Beijing Key Laboratory of Urogenital Diseases (male) Molecular Diagnosis and Treatment Center, Beijing, China.

出版信息

Front Genet. 2022 Jan 21;12:795611. doi: 10.3389/fgene.2021.795611. eCollection 2021.

DOI:10.3389/fgene.2021.795611
PMID:35126463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8815861/
Abstract

N-methyladenosine (mA) is the most extensive messenger RNA modification. Despite recent advances in the biological roles of mA, its role in the development and progression of renal cell carcinoma (RCC) remains unclear. In this study, we gained the transcriptome-wide mA profile and gene expression pattern in RCC and paired adjacent peritumoral tissues by meRIP-seq and RNA-seq. mA modifications of mRNAs were validated by meRIP-qPCR in tissues, and targeted methylation or demethylation was validated by using a CRISPR-Cas13b-based tool in RCC cell lines. Our findings showed that there were 13,805 mA peaks among 5,568 coding gene transcripts (mRNAs) in adjacent tissues and 24,730 mA peaks among 6,866 mRNAs in tumor tissues. Furthermore, mA modification sites were usually located in the coding sequences (CDS), and some near the start and stop codons. Gene Ontology analysis revealed that coding genes had differential N-methyladenosine sites and were enriched in kidney development and cancer-related signaling pathways. We also found that different levels of mA modifications could regulate gene expression. In summary, our results provided evidence for studying the potential function of RNA mA modification and mA-mediated gene expression regulation in human RCC.

摘要

N-甲基腺苷(mA)是最广泛存在的信使核糖核酸修饰。尽管近年来在mA的生物学作用方面取得了进展,但其在肾细胞癌(RCC)发生发展中的作用仍不清楚。在本研究中,我们通过甲基化RNA免疫沉淀测序(meRIP-seq)和RNA测序(RNA-seq)获得了RCC及其配对的相邻肿瘤旁组织的全转录组mA图谱和基因表达模式。通过组织中的甲基化RNA免疫沉淀定量PCR(meRIP-qPCR)验证了mRNA的mA修饰,并在RCC细胞系中使用基于CRISPR-Cas13b的工具验证了靶向甲基化或去甲基化。我们的研究结果表明,相邻组织中5568个编码基因转录本(mRNA)中有13805个mA峰,肿瘤组织中6866个mRNA中有24730个mA峰。此外,mA修饰位点通常位于编码序列(CDS)中,有些靠近起始密码子和终止密码子。基因本体分析显示,编码基因具有不同的N-甲基腺苷位点,并且在肾脏发育和癌症相关信号通路中富集。我们还发现不同水平的mA修饰可以调节基因表达。总之,我们的结果为研究RNA mA修饰的潜在功能以及mA介导的基因表达调控在人类RCC中的作用提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/57a4cbec82d2/fgene-12-795611-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/9b5a530e3112/fgene-12-795611-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/7065da54ef15/fgene-12-795611-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/b9034f97404c/fgene-12-795611-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/d62ccd614db2/fgene-12-795611-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/8509ba65e8aa/fgene-12-795611-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/ba7e4c5d2960/fgene-12-795611-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/57a4cbec82d2/fgene-12-795611-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/9b5a530e3112/fgene-12-795611-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/7065da54ef15/fgene-12-795611-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/b9034f97404c/fgene-12-795611-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/d62ccd614db2/fgene-12-795611-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/8509ba65e8aa/fgene-12-795611-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/ba7e4c5d2960/fgene-12-795611-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4efa/8815861/57a4cbec82d2/fgene-12-795611-g007.jpg

相似文献

1
mA-mRNA Methylation Regulates Gene Expression and Programmable mA Modification of Cellular RNAs With CRISPR-Cas13b in Renal Cell Carcinoma.N6-甲基腺苷(mA)-信使核糖核酸(mRNA)甲基化调控基因表达以及利用CRISPR-Cas13b对肾细胞癌中细胞RNA进行可编程的mA修饰
Front Genet. 2022 Jan 21;12:795611. doi: 10.3389/fgene.2021.795611. eCollection 2021.
2
Transcriptome-Wide Map of N-Methyladenosine Methylome Profiling in Human Bladder Cancer.人膀胱癌中N-甲基腺苷甲基化组图谱的全转录组范围图谱
Front Oncol. 2021 Nov 15;11:717622. doi: 10.3389/fonc.2021.717622. eCollection 2021.
3
ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.ZNF677 通过 N6-甲基腺苷和转录抑制 CDKN3 抑制肾细胞癌进展。
Clin Transl Med. 2022 Jun;12(6):e906. doi: 10.1002/ctm2.906.
4
Transcriptome-wide N -methyladenosine methylome profiling of porcine muscle and adipose tissues reveals a potential mechanism for transcriptional regulation and differential methylation pattern.猪肌肉和脂肪组织的全转录组N - 甲基腺苷甲基化组分析揭示了转录调控和差异甲基化模式的潜在机制。
BMC Genomics. 2017 Apr 28;18(1):336. doi: 10.1186/s12864-017-3719-1.
5
Dynamic Patterns of N6-Methyladenosine Profiles of Messenger RNA Correlated with the Cardiomyocyte Regenerability during the Early Heart Development in Mice.动态的 N6-甲基腺苷信使 RNA 谱模式与早期心脏发育过程中心肌细胞再生能力相关。
Oxid Med Cell Longev. 2021 Aug 6;2021:5537804. doi: 10.1155/2021/5537804. eCollection 2021.
6
Validated Impacts of N6-Methyladenosine Methylated mRNAs on Apoptosis and Angiogenesis in Myocardial Infarction Based on MeRIP-Seq Analysis.基于MeRIP-Seq分析的N6-甲基腺苷甲基化mRNA对心肌梗死细胞凋亡和血管生成的验证影响
Front Mol Biosci. 2022 Jan 28;8:789923. doi: 10.3389/fmolb.2021.789923. eCollection 2021.
7
Comprehensive analysis of the transcriptome-wide mA methylome in invasive malignant pleomorphic adenoma.侵袭性恶性多形性腺瘤中转录组范围的 mA 甲基化组的综合分析。
Cancer Cell Int. 2021 Mar 2;21(1):142. doi: 10.1186/s12935-021-01839-6.
8
Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma.长链非编码RNA NEAT1的靶向甲基化抑制肾细胞癌的恶性程度。
Front Cell Dev Biol. 2021 Dec 9;9:777349. doi: 10.3389/fcell.2021.777349. eCollection 2021.
9
-Methyladenosine Methylomic Landscape of Lung Tissues in Murine Acute Allergic Asthma.- 急性变应性哮喘小鼠肺部组织的甲基腺苷甲基组学图谱
Front Immunol. 2021 Oct 19;12:740571. doi: 10.3389/fimmu.2021.740571. eCollection 2021.
10
EGR2-mediated regulation of mA reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization.EGR2介导的mA阅读器IGF2BP蛋白调控通过增强S1PR3 mRNA稳定性驱动肾细胞癌的肿瘤发生和转移。
Cell Death Dis. 2021 Jul 29;12(8):750. doi: 10.1038/s41419-021-04038-3.

引用本文的文献

1
The role of N6-methyladenosine (mA) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential.N6-甲基腺苷(m⁶A)RNA甲基化修饰在肾脏疾病中的作用:从机制到治疗潜力
PeerJ. 2025 Aug 27;13:e19940. doi: 10.7717/peerj.19940. eCollection 2025.
2
The role of RNA modification in urological cancers: mechanisms and clinical potential.RNA修饰在泌尿系统癌症中的作用:机制与临床潜力
Discov Oncol. 2023 Dec 20;14(1):235. doi: 10.1007/s12672-023-00843-8.
3
N6-methyladenosine methylation in kidney injury.肾脏损伤中的N6-甲基腺苷甲基化

本文引用的文献

1
The N6-Methyladenosine Features of mRNA and Aberrant Expression of m6A Modified Genes in Gastric Cancer and Their Potential Impact on the Risk and Prognosis.mRNA的N6-甲基腺苷特征及m6A修饰基因在胃癌中的异常表达及其对风险和预后的潜在影响
Front Genet. 2020 Nov 4;11:561566. doi: 10.3389/fgene.2020.561566. eCollection 2020.
2
Programmable mA modification of cellular RNAs with a Cas13-directed methyltransferase.利用 Cas13 指导的甲基转移酶对细胞 RNA 进行可编程的 mA 修饰。
Nat Biotechnol. 2020 Dec;38(12):1431-1440. doi: 10.1038/s41587-020-0572-6. Epub 2020 Jun 29.
3
Targeting MUC15 Protein in Cancer: Molecular Mechanisms and Therapeutic Perspectives.
Clin Epigenetics. 2023 Oct 21;15(1):170. doi: 10.1186/s13148-023-01586-7.
4
The current landscape of m6A modification in urological cancers.尿路上皮癌中 m6A 修饰的现状。
PeerJ. 2023 Sep 7;11:e16023. doi: 10.7717/peerj.16023. eCollection 2023.
靶向 MUC15 蛋白治疗癌症:分子机制与治疗前景。
Curr Cancer Drug Targets. 2020;20(9):647-653. doi: 10.2174/1568009620666200601140639.
4
Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein.靶向 mRNA 去甲基化的工程化 dCas13b-ALKBH5 融合蛋白。
Nucleic Acids Res. 2020 Jun 4;48(10):5684-5694. doi: 10.1093/nar/gkaa269.
5
N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.N6-甲基腺苷 RNA 甲基化调控因子参与肾透明细胞癌的恶性进展,并具有预后价值。
Oncol Rep. 2020 May;43(5):1591-1605. doi: 10.3892/or.2020.7524. Epub 2020 Feb 28.
6
N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells.N6-甲基腺苷调节 TGFβ1 的表达和分泌,影响癌细胞的上皮-间充质转化。
Cells. 2020 Jan 25;9(2):296. doi: 10.3390/cells9020296.
7
The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.m6A 甲基转移酶 METTL3 通过调节 JUNB 促进转化生长因子-β诱导的肺癌细胞上皮-间充质转化。
Biochem Biophys Res Commun. 2020 Mar 26;524(1):150-155. doi: 10.1016/j.bbrc.2020.01.042. Epub 2020 Jan 22.
8
ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1.ALKBH5 通过降低 lncRNA NEAT1 的甲基化促进胃癌的侵袭和转移。
J Physiol Biochem. 2019 Aug;75(3):379-389. doi: 10.1007/s13105-019-00690-8. Epub 2019 Jul 9.
9
CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.CDCA2 通过体外和体内激活 AKT/CCND1 通路促进结直肠癌细胞的增殖。
BMC Cancer. 2019 Jun 13;19(1):576. doi: 10.1186/s12885-019-5793-z.
10
Detection of N6‑methyladenosine modification residues (Review).N6-甲基腺苷修饰残基的检测(综述)。
Int J Mol Med. 2019 Jun;43(6):2267-2278. doi: 10.3892/ijmm.2019.4169. Epub 2019 Apr 18.